Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6ce72abebb970ffce43a787ecdb4991 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf82b2c04febd9f5fc6ead8595272b9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26eba5d2a224838cc0845600fc0e08e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a9388a4598070576ac2ec2b30c6cc70 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
filingDate |
2008-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_814fb76115bb4ce39a669ecc9313b7d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_940cc93bfc5d0789151e6ff67eaf9655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56b5916f754507f1f209524c83719824 |
publicationDate |
2008-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008108322-A2 |
titleOfInvention |
Composition and method for protecting mitochondria |
abstract |
The present invention relates to a composition for protecting mitochondria from damage in a mammalian subject which comprises a specific prostaglandin compound. The present invention also relates to a pharmaceutical composition for treating mitochondrial dysfunction as well as a condition associated with mitochondrial dysfunction in a mammalian subject which comprises a prostaglandin compound. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009104807-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2009216067-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8871752-B2 |
priorityDate |
2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |